We are live on ! Find out more
FAM

Fred Alger Management Portfolio holdings

AUM $30B
1-Year Est. Return 76.99%
This Fund
S&P 500
This Quarter Est. Return
+43.51%
1 Year Est. Return
+76.99%
3 Year Est. Return
+326.24%
5 Year Est. Return
+435.69%
10 Year Est. Return
+2,724.6%
AUM
$30B
AUM Growth
+$7.24B
Cap. Flow
+$923M
Cap. Flow %
3.08%
Top 10 Hldgs %
54.41%
Holding
509
New
65
Increased
131
Reduced
225
Closed
84

Top Buys

Rank Stock Value
1
SPCX
SpaceX
SPCX
+$982M
2
NVDA icon
NVIDIA
NVDA
+$276M
3
NVO
Novo Nordisk
NVO
+$211M
4
LITE icon
Lumentum
LITE
+$203M
5
AMD icon
Advanced Micro Devices
AMD
+$185M

Sector Composition

Rank Sector Weight
1 Technology 41.55%
2 Communication Services 18%
3 Industrials 12.18%
4 Consumer Discretionary 11.21%
5 Healthcare 9.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RDDT icon
301
Reddit
RDDT
$28.7B
$2.46M 0.01%
14,154
-9,914
-41% -$1.59M
MANH icon
302
Manhattan Associates
MANH
$12.1B
$2.37M 0.01%
17,020
-22
-0.1% -$3.03K
NKTR icon
303
Nektar Therapeutics
NKTR
$2.58B
$2.35M 0.01%
33,673
-19,499
-37% -$1.43M
EQIX icon
304
Equinix
EQIX
$103B
$2.33M 0.01%
1,906
-2,629
-58% -$2.81M
DKS icon
305
Dick's Sporting Goods
DKS
$11.8B
$2.28M 0.01%
10,058
-5
-0% -$1.1K
IDA icon
306
Idacorp
IDA
$7.98B
$2.26M 0.01%
14,946
-210
-1% -$30.2K
PSNL icon
307
Personalis
PSNL
$1.77B
$2.22M 0.01%
+165,579
New +$1.35M
TEM
308
Tempus AI
TEM
$11.7B
$2.21M 0.01%
38,065
+6,235
+20% +$313K
CDRE icon
309
Cadre Holdings
CDRE
$1.27B
$2.2M 0.01%
77,004
-305,949
-80% -$9.22M
TNGX icon
310
Tango Therapeutics
TNGX
$3.83B
$2.16M 0.01%
69,038
-81,032
-54% -$2M
XPO icon
311
XPO
XPO
$22.3B
$2.14M 0.01%
10,400
+7,643
+277% +$1.62M
CMCSA icon
312
Comcast
CMCSA
$93.4B
$2.12M 0.01%
86,209
-50,569
-37% -$1.31M
MC icon
313
Moelis & Co
MC
$5.09B
$2.1M 0.01%
32,127
-507
-2% -$33.2K
MANE
314
Veradermics Inc
MANE
$4.34B
$2.09M 0.01%
+17,039
New +$1.6M
ADI icon
315
Analog Devices
ADI
$176B
$2.09M 0.01%
5,262
-3,541
-40% -$1.4M
PANW icon
316
Palo Alto Networks
PANW
$275B
$2.09M 0.01%
6,128
-7,595
-55% -$1.74M
MSCI icon
317
MSCI
MSCI
$40.1B
$2.08M 0.01%
+3,707
New +$2.16M
AVAV icon
318
AeroVironment
AVAV
$7.56B
$2.07M 0.01%
12,566
-34,841
-73% -$6.24M
KRYS icon
319
Krystal Biotech
KRYS
$10.4B
$2.01M 0.01%
+5,418
New +$1.62M
RPRX icon
320
Royalty Pharma
RPRX
$27B
$1.95M 0.01%
34,725
+762
+2% +$39.7K
SLN
321
Silence Therapeutics
SLN
$851M
$1.94M 0.01%
+177,000
New +$1.25M
TGTX icon
322
TG Therapeutics
TGTX
$8.53B
$1.93M 0.01%
35,165
+16,577
+89% +$678K
RIOT icon
323
Riot Platforms
RIOT
$8.35B
$1.92M 0.01%
70,102
-1,030
-1% -$23.2K
AS icon
324
Amer Sports
AS
$16.7B
$1.87M 0.01%
55,240
+39,582
+253% +$1.39M
RCUS icon
325
Arcus Biosciences
RCUS
$3.7B
$1.87M 0.01%
+60,494
New +$1.5M

Similar funds

Fred Alger Management's Q2 2026 Portfolio in Review

As of Q2 2026, Fred Alger Management held 509 positions worth $30B, up 32% from $22.8B the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Fred Alger Management deployed $923M of net new capital in Q2 2026, opening 65 new positions and adding to 131 existing holdings. Its largest new stake was SpaceX: 5,779,419 shares worth $987M.

By sector, the portfolio is most concentrated in Technology at 42% of assets, up from 39% a quarter earlier, followed by Communication Services and Industrials.

On the sell side, the largest reduction was Nebius Group N.V., an estimated $767M trimmed.

  • Fred Alger Management's largest Q2 2026 buy was SpaceX: 5,779,419 shares worth $987M.
  • Fred Alger Management added most to NVIDIA in Q2 2026, an estimated $276M increase.
  • Fred Alger Management's biggest Q2 2026 reduction was Nebius Group N.V., cutting an estimated $767M.
  • Fred Alger Management fully exited Palantir in Q2 2026, selling an estimated $95.2M.
  • Fred Alger Management's ten largest holdings make up 54% of its $30B portfolio in Q2 2026.
  • Fred Alger Management opened 65 new positions and closed 84 in Q2 2026.
  • Fred Alger Management's portfolio value rose 32% quarter-over-quarter to $30B.

Based on Fred Alger Management's 13F filing for Q2 2026, filed 14 Aug 2026.